|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/506 | |
| C12Q 1/68 |
| (11) | Patento numeris | 1909795 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06772756.0 |
| Europos patento paraiškos padavimo data | 2006-06-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-04-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-04-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/022564 |
| Data | 2006-06-09 |
| (87) | Numeris | WO 2006/135790 |
| Data | 2006-12-21 |
| (30) | Numeris | Data | Šalis |
| 689113 P | 2005-06-09 | US | |
| 736668 P | 2005-11-15 | US | |
| 748418 P | 2005-12-08 | US |
| (72) |
LEE, Francis, Y., US
HEINRICH, Michael, C., US
|
| (73) |
Bristol-Myers Squibb Company,
Lawrenceville-Princeton Road, Princeton NJ 08543-4000,
US
The United States of America, as Represented by the Department of Veterans Affairs, 810 Vermont Avenue, NW, Washington, D.C. 20420, US Oregon Health and Science University, 2525 SW First Avenue, Suite 120, Mail code AD120, Portland, Oregon 97201, US |
| (54) | PHARMACEUTICAL COMPOSITION FOR USE IN TREATING INDIVIDUALS EXHIBITING MUTANT KIT PROTEIN |
| PHARMACEUTICAL COMPOSITION FOR USE IN TREATING INDIVIDUALS EXHIBITING MUTANT KIT PROTEIN |